HBS Collaborators are required to follow the four aspects of our publication policy:
1. Collaborators are required to keep HBS investigators updated on the progress of the study by providing a draft manuscript 3 weeks prior to submission to email@example.com. Depending on the level of involvement in a specific project, HBS investigators may participate as co-authors.
2. Include the following HBS Study Investigators Acknowledgement Section in the manuscript:
“The Harvard Biomarkers Study (“HBS”); https://www.bwhparkinsoncenter.org) is a collaborative initiative of Brigham and Women’s Hospital and Massachusetts General Hospital, co-directed by Dr. Clemens Scherzer and Dr. Bradley T. Hyman. The HBS Investigators have not participated in reviewing the current manuscript. The HBS Study Investigators are:
Harvard Biomarkers Study. Co-Directors: Brigham and Women’s Hospital: Clemens R. Scherzer, Massachusetts General Hospital: Bradley T. Hyman; Investigators and Study Coordinators: Brigham and Women’s Hospital: Yuliya Kuras, Karbi Choudhury, Michael T. Hayes, Aleksandar Videnovic, Nutan Sharma, Vikram Khurana, Claudio Melo De Gusmao, Reisa Sperling; Massachusetts General Hospital: John H. Growdon, Michael A. Schwarzschild, Albert Y. Hung, Alice W. Flaherty, Deborah Blacker, Anne-Marie Wills, Steven E. Arnold, Ann L. Hunt, Nicte I. Mejia, Anand Viswanathan, Stephen N. Gomperts, Mark W. Albers, Maria Allora-Palli, David Hsu, Alexandra Kimball, Scott McGinnis, John Becker, Randy Buckner, Thomas Byrne, Maura Copeland, Bradford Dickerson, Matthew Frosch, Theresa Gomez-Isla, Steven Greenberg, Julius Hedden, Elizabeth Hedley-Whyte, Keith Johnson, Raymond Kelleher, Aaron Koenig, Maria Marquis-Sayagues, Gad Marshall, Sergi Martinez-Ramirez, Donald McLaren, Olivia Okereke, Elena Ratti, Christopher William, Koene Van Dij, Shuko Takeda, Anat Stemmer-Rachaminov, Jessica Kloppenburg, Catherine Munro, Rachel Schmid, Sarah Wigman, Sara Wlodarcsyk; Data Coordination: Brigham and Women’s Hospital: Thomas Yi; Biobank Management Staff: Brigham and Women’s Hospital: Idil Tuncali.”
3. Include the following HBS Funding Acknowledgement in your manuscript:
We thank all study participants and their families for their invaluable contributions. HBS is made possible by generous support from the Harvard NeuroDiscovery Center, with additional contributions from the Michael J Fox Foundation, NINDS U01NS082157, U01NS100603, and the Massachusetts Alzheimer’s Disease Research Center NIA P50AG005134.
4. Reference a primary HBS publication in your manuscript:
Liu et al. (2017). Prediction of cognition in Parkinson’s disease with a clinical-genetic score: a longitudinal analysis of nine cohorts, Lancet Neurology, 16, 620-629. PMID 28629879.
Ding et al. (2013). Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study, Neurology, 81, 1531-7. PMID: 24068787.
Ding et al. (2011). Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study, Movement Disorders, 26, 2283-6. PMID: 21953863.
Mohammadi (2013) The Harvard Biomarker Study’s big plan. Lancet Neurology, 12, 739-40. PMID: 23809962.
Note that publication requirement 1 is waived for investigators whose use of HBS data is limited to the harmonized HBS data available through the AMP PD portal (without use of additional HBS data or biosamples).